UBS O'Connor’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $847K | Buy |
90,441
+31,003
| +52% | +$290K | 0.04% | 225 |
|
|
2025
Q1 | $730K | Sell |
59,438
-30,794
| -34% | -$378K | 0.02% | 194 |
|
|
2024
Q4 | $1.19M | Buy |
90,232
+751
| +0.8% | +$9.93K | 0.03% | 206 |
|
|
2024
Q3 | $1.72M | Sell |
89,481
-20,973
| -19% | -$404K | 0.04% | 192 |
|
|
2024
Q2 | $2.27M | Buy |
110,454
+2,023
| +2% | +$41.5K | 0.06% | 172 |
|
|
2024
Q1 | $2.58M | Buy |
108,431
+12,482
| +13% | +$297K | 0.07% | 139 |
|
|
2023
Q4 | $2.07M | Buy |
+95,949
| New | +$2.07M | 0.07% | 166 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 554 |
|